MP54-04 A PHASE II STUDY OF CHECK POINT INHIBITOR, DURVALUMAB (MEDI4736) FOR BACILLUS CALMETTE-GUERIN UNRESPONSIVE CARCINOMA IN SITU OF THE BLADDER. (May 2022) - Li, Roger; Rose, Kyle; Poch, Michael; Spiess, Philippe; Gilbert, Scott; Sexton, Wade; Zhang, Jingsong